Psilocybin research conducted by Dr. Roland Griffiths at the Johns Hopkins University School of Medicine has been featured in TIME magazine. Please follow the link.

The continuing study at Johns Hopkins University School of Medicine on psilocybin and its potential in the treatment of anxiety and depression in those facing life threatening cancer is the topic in the journal  Psychopharmacology . Please follow the links to the  press release and the Yahoo news story for more information.


Also take note of an observation made by “Jerome Jaffe, M.D., of the University of Maryland School of Medicine, who served as the first White House “Drug Czar” and has also been a consultant to the World Health Organization on drug issues.” “The Hopkins psilocybin studies clearly demonstrate that this route to the mystical is not to be walked alone. But they have also demonstrated significant and lasting benefits. That raises two questions: Could psilocybin-occasioned experiences prove therapeutically useful, for example in dealing with the psychological distress experienced by some terminal patients? And should properly-informed citizens, not in distress, be allowed to receive psilocybin for its possible spiritual benefits, as we now allow them to pursue other possibly risky activities such as cosmetic surgery and mountain-climbing?”

The Hopkins  study is on going and recruiting volunteers.

The complete 2011 presentations of speakers at MANIFESTING THE MIND in Madison Wisconsin are now available on-line. Please follow the link and enjoy an incredible array of speakers discussingconsciousness and the neurology involved in the process.



Posted on January 21, 2011

Heffter scientists will be speaking at this conference, in Madison, WI on April 28-29, 2011:

OVERVIEW: The over-arching theme of this Forum’s is exploration of the Mind-Brain phenomenon and how this relates to human consciousness. The challenge faced by planners of Manifesting the Mind was to respect the many interests of our audience, to cover a wide range of topics — ethnobotany to neurotransmitters to recent clinical reports on the use of entheogens. One goal of the Forum is the exploration of these diverse topics in understanding human potential and how we conceptualize the next step in the evolution of consciousness on this planet.

Screening will be in Namaste Hall, 1453 Mission Street, 3rd floor, San Francisco, CA. Included in the film is an interview with Annie Levy about her experience taking psilocybin as a cancer patient in Dr. Charles Grob’s research study.

7:00 pm Welcome by Joseph Subbiondo

7:15 to 8:30 pm Film screening

8:30 to 9:15 pm Panel discussion with Robert Barnhart, Roslyn Dauber, Frank Echenhofer, and Charles Grob.

On February 24, 2010, Scienceline published this story about Pam Sakuda, the first person in decades to talk about the experience of psychedelic treatment in a research study.

Read the Scienceline story here…


The Spring, 2010 issue of NYU Physician published the history of the Heffter-supported study at NYU and a subject’s recounting of how he “experienced a sense of transformation in his ability to feel supported and loved” with psilocybin treatment.

Afterwords, he said, “This has helped me resolve past issues about my parents and siblings. Now, I can die unburdened by the angst of my childhood.”

Read the NYU Physician story here…


In April, 2010, both ABC News and the Associated Press published reports about cancer patient Nicky Edlich’s story of her “revelatory” psilocybin treatment at the Heffter-supported project at New York University, led by Dr. Stephen Ross, MD.

Read the ABC News story here…

Read the AP story here…


On April 21, 2010, CNN’s Campbell Brown interviewed Heffter-supported researcher Dr. Stephen Ross and CNN medical advisor Dr. Sanjay Gupta about the benefits of psilocybin research.

Watch the video here…